MedTrace Logo

Cognitive Remediation for Cocaine Dependence

NCT01393457 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2018-03-29

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate treatments designed to improve cocaine treatment success by combining medications that target cocaine-related cognitive impairments.

Conditions

  • Cocaine Dependence

Interventions

DRUG

levodopa/carbidopa

800/200 mg/d

DRUG

Ropinirole 2 mg/d

2 mg/d

DRUG

Placebo

sugar pill

DRUG

Ropinirole 4 mg/d

4 mg/d

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2017-02-28
Completion
2017-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01393457 on ClinicalTrials.gov